WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.
Hotter Today but Cooldown for Wednesday UPDATE
Employees Still Waiting to Hear From Branson Tri-Lakes Newspaper Management
Informational Meeting About Fire and Police Tax Thursday
Tick Season Is in Full Force
What is the Potential Heat Index Readings for This Week? Update